Precisely where it matters

In surgical oncology, such as breast conserving surgery, rapid assessment of the excised specimen is of utmost importance. You want to be confident that your surgery reached its goal of resecting the target lesion, so that your patients recovery can be promoted.

Discover AURA 10

The first PET-CT specimen imager for the OR

The XEOS AURA 10 is the first-ever PET-CT Specimen Imager for the OR, offering surgeons and imaging specialists the sensitivity of PET imaging, combined with submillimeter spatial resolution.

AURA 10 has made molecular imaging available in the OR. As a result, surgeons and imaging specialists have never been able to perform specimen imaging with so much confidence. Ultimately, patients will be the ones who benefit.

Discover how AURA 10 creates impact for your patients

Molecular imaging
in an instance

Molecular imaging has been the gold standard in oncology for years. Whole-body PET-CT scanners have proven to be invaluable for the diagnosis and follow up of cancers, because they provide unparalleled sensitivity for the detection and localization of malignant cells.

Imagine you could obtain this level of precision within 10 minutes after excision, right at the point of surgery, without having to transport your specimen over to the radiology department. Imagine how this could boost your surgical confidence and improve the wellbeing of your patients.

Discover the benefits

Latest news

show all news
7 September 2023

AURA 10 FDA approved!

Read more
22 August 2023

WEBINAR - Molecular imaging at the point of surgery: intraoperative specimen PET-CT imaging.

Read more

Subscribe to
our newsletter